Variable | Resultsa (no stroke) (N = 212) | Resultsa (stroke) (N = 95) | p-value | Odds Ratio | CI (95%) |
---|---|---|---|---|---|
Extracerebral arterial embolic events | 34 (16.0%) | 35 (36.8%) | 0.005 | 2.45 | 1.31–4.60 |
Acute liver failure | 15 (7.1%) | 18 (18.9%) | 0.065 | 2.37 | 0.95–5.91 |
Dental focus of infection | 0.016 | 3.30 | 1.25–8.72 | ||
Intracardiac medical devices other than artificial heart valves (e.g. MitraClip, ICD, pacemaker) | 53 (25.0%) | 10 (10.5%) | 0.030 | 0.41 | 0.18–0.92 |
Congenital heart disease (e.g. bicuspid aortic valve) | 15 (7.1%) | 2 (2.1%) | 0.050 | 0.20 | 0.04–0.99 |
Previous heart disease other than congenital heart disease | 75 (35.4%) | 23 (24.2%) | 0.183 | 0.65 | 0.35–1.23 |
Acute renal failure requiring HD | 39 (18.4%) | 26 (27.4%) | 0.891 | 0.95 | 0.47–1.92 |
Pathogen isolated in blood culture (no pathogen found = ref) | |||||
Staphylococcus aureus | 39 (18.4) | 34 (36.2%) | 0.850 | 0.92 | 0.40–2.13 |
Staphylococcus epidermidis | 28 (13.2%) | 6 (6.4%) | 0.057 | 0.32 | 0.10–1.03 |
Streptococcus mitis/oralis | 13 (6.1%) | 5 (5.3%) | 0.128 | 0.35 | 0.09–1.35 |
Enterococcus faecalis | 24 (11.3%) | 10 (10.6%) | 0.609 | 0.77 | 0.27–2.14 |
Other | 85 (40.1%) | 20 (21.3%) | 0.006 | 0.31 | 0.13–0.71 |